Twist Bioscience Corp (TWST): Operating Income
-$139.46M
Year ended 2026-09-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2026-09-30 | -$139.46M | n/m | 2026-11-16, From 2025-10-01 |
| 2025-09-30 | -$136.26M | n/m | 2026-11-16, From 2024-10-01 |
| 2024-09-30 | -$220.83M | n/m | 2026-11-16, From 2023-10-01 |
| 2023-09-30 | -$217.16M | n/m | 2025-11-17, From 2022-10-01 |
| 2022-09-30 | -$234.78M | n/m | 2024-11-18, From 2021-10-01 |
| 2021-09-30 | -$152.73M | n/m | 2023-11-21, From 2020-10-01 |
| 2020-09-30 | -$140.08M | n/m | 2023-06-05, From 2019-10-01 |
| 2019-09-30 | -$108.85M | n/m | 2021-11-23, From 2018-10-01 |
| 2018-09-30 | -$70.56M | n/m | 2020-11-27, From 2017-10-01 |
| 2017-09-30 | -$58.48M | n/a | 2019-12-13, From 2016-10-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | 2026-09-30 | -$139.46M | n/m |
| Tarsus Pharmaceuticals, Inc. (TARS) | 2025-12-31 | -$70.97M | n/m |
| ADMA Biologics, Inc. (ADMA) | 2025-12-31 | $191.44M | +37.7% |
| Immunocore Holdings plc (IMCR) | 2025-12-31 | -$45.35M | n/m |
| Krystal Biotech, Inc. (KRYS) | 2025-12-31 | $161.29M | +145.3% |
| Repligen Corp (RGEN) | 2025-12-31 | $55.17M | n/m |
| Adaptive Biotechnologies Corp (ADPT) | 2025-12-31 | -$57.12M | n/m |
| Vericel Corp (VCEL) | 2025-12-31 | $11.04M | +144.4% |
| Iovance Biotherapeutics, Inc. (IOVA) | 2025-12-31 | -$403.36M | n/m |
Compare TWST, TARS, ADMA, IMCR side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗